or Try an Advanced Search...

    Technical Analysis for EWTX - Edgewise Therapeutics, Inc.

    Grade Last Price % Change Price Change
    C 17.90 1.22% 0.22
    EWTX closed up 1.38 percent on Wednesday, May 15, 2024, on 1.24 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Down
    Historical EWTX trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 1.22%
    NR7 Range Contraction 1.22%
    NR7-2 Range Contraction 1.22%
    Wide Bands Range Expansion 1.22%
    20 DMA Resistance Bearish 2.61%
    MACD Bearish Signal Line Cross Bearish 2.61%
    50 DMA Support Bullish 2.61%
    NR7 Range Contraction 2.61%
    Doji - Bullish? Reversal 2.61%
    Wide Bands Range Expansion 2.61%
    Older End-of-Day Signals for EWTX ...

       Recent Intraday Alerts

    Alert Time
    Up 2% 8 minutes ago
    20 DMA Resistance about 1 hour ago
    Rose Above 20 DMA about 1 hour ago
    60 Minute Opening Range Breakout about 1 hour ago
    Up 1% about 2 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    EWTX Chart by TradingView
    Basic chart:

    Profile

    Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. It offers a precision medicine muscle platform that generates programs to address various muscle disorders, such as Duchenne, Becker, and limb girdle muscular dystrophies. The company develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. Edgewise Therapeutics, Inc. was founded in 2017 and is headquartered in Boulder, Colorado.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Muscular Dystrophy Small Molecule Therapies Limb Girdle Muscular Dystrophies Muscle Disorders

    Is EWTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 10 Edgewise: Intriguing Drug Candidate, But Consider Selling After Recent Run
    May 10 Edgewise Therapeutics Inc (EWTX) Reports First Quarter 2024 Financial Results
    May 10 Edgewise Therapeutics files mixed securities shelf
    May 10 Edgewise Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference on May 15, 2024
    May 9 Edgewise Therapeutics GAAP EPS of -$0.33
    May 9 Top 5 Health Care Stocks That Could Sink Your Portfolio In Q2
    May 9 Edgewise Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
    May 7 Edgewise Therapeutics Appoints Arlene Morris to its Board of Directors
    May 7 Edgewise Therapeutics doses first subject in HCM drug trial
    May 6 Edgewise Therapeutics Doses First Patient in Phase 2 CIRRUS-HCM Trial of EDG-7500 in Obstructive Hypertrophic Cardiomyopathy (HCM)
    See more EWTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 21.6
    52 Week Low 5.12
    Average Volume 736,932
    200-Day Moving Average 11.34
    50-Day Moving Average 17.26
    20-Day Moving Average 17.79
    10-Day Moving Average 19.22
    Average True Range 1.25
    RSI (14) 48.45
    ADX 21.22
    +DI 24.24
    -DI 22.76
    Chandelier Exit (Long, 3 ATRs) 17.86
    Chandelier Exit (Short, 3 ATRs) 18.64
    Upper Bollinger Bands 21.62
    Lower Bollinger Band 13.96
    Percent B (%b) 0.49
    BandWidth 43.09
    MACD Line 0.46
    MACD Signal Line 0.61
    MACD Histogram -0.1476
    Fundamentals Value
    Market Cap 1.63 Billion
    Num Shares 92.3 Million
    EPS -1.40
    Price-to-Earnings (P/E) Ratio -12.63
    Price-to-Sales 0.00
    Price-to-Book 6.29
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 18.87
    Resistance 3 (R3) 18.89 18.51 18.67
    Resistance 2 (R2) 18.51 18.21 18.50 18.60
    Resistance 1 (R1) 18.10 18.03 17.91 18.08 18.54
    Pivot Point 17.72 17.72 17.63 17.71 17.72
    Support 1 (S1) 17.31 17.42 17.12 17.29 16.82
    Support 2 (S2) 16.93 17.24 16.92 16.76
    Support 3 (S3) 16.52 16.93 16.69
    Support 4 (S4) 16.50